Volume 5, 2019
|Number of page(s)||7|
|Published online||01 November 2019|
Charnley femoral cemented stem with a permeable and resorbable cement restrictor and low-viscosity cement
Clinical and radiographical evaluation of 100 cases at a mean follow-up of 6.55 years
Centre Osteo Articulaire, 5 rue Raoul Blanchard, 38000 Grenoble, France
2 Institut d’orthopédie, 103 rue Coste, 69300 Caluire, France
3 Consultant, 25 chemin jan Baptiste Gillard, 69300 Caluire et cuire, France
* Corresponding author: firstname.lastname@example.org
Accepted: 27 September 2019
Introduction: In 1979, in his first book dealing with low-friction arthroplasty (LFA), Charnley highlighted the use of a cement restrictor. Breusch and Malchau described in 2005 the “second-generation cementing technique.”
The main objective of this study was to report on the clinical survival of 100 cases of Charnley femoral component implanted in 2007 and 2008 using a permeable and resorbable cement restrictor and a low-viscosity antibiotic-loaded cement.
The secondary objectives were to analyze the complications and side effects and the accuracy of the device positioning.
Material and methods: This was a monocentric retrospective review of a prospectively compiled database.
Diaphyseal restrictor was biodegradable and permeable to gas, blood, and fluids to avoid intramedullary over pression during cementation. The cement was a low-viscosity antibiotic-loaded cement.
Among 3555 patients, we selected the first continuous 100 cases of patients where we implanted the device.
Survival probability was computed according to Kaplan–Meier method.
Results: Mean follow-up was 6.55 ± 2.6 (range 1–11).
Considering femoral component revision as the endpoint, survival rate was 100%.
No patients died intraoperatively, none in the first month and the first year after surgery.
No early periprosthetic fractures have been reported.
Discussion: As described initially by Charnley, the use of a cement restrictor was highly recommended through the different generations of cementing techniques.
Hypotensive episodes and cardiac arrest have been reported during cement insertion.
In our series, we did not deplore any adverse effect related to the cementation.
Conclusion: Our study demonstrates a 100% survival rate of a cemented femoral component without adverse effects when using routinely a resorbable and permeable cement restrictor and a low-viscosity cement. Bone cement is still a fantastic ally for the surgeon and the patients.
Key words: Resorbable and permeable cement restrictor / Cementation / Cardiovascular side effects
© The Authors, published by EDP Sciences, 2019
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.